97 related articles for article (PubMed ID: 30088402)
21. A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.
Lorenz K; Scheller Y; Bell K; Grus F; Ponto KA; Bock F; Cursiefen C; Flach J; Gehring M; Peto T; Silva R; Tal Y; Pfeiffer N
Trials; 2017 Mar; 18(1):128. PubMed ID: 28302155
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.
Kim M; Lee C; Payne R; Yue BY; Chang JH; Ying H
Surv Ophthalmol; 2015; 60(6):524-35. PubMed ID: 25980779
[TBL] [Abstract][Full Text] [Related]
23. The mechanism and therapeutic strategies for neovascular glaucoma secondary to diabetic retinopathy.
Tang Y; Shi Y; Fan Z
Front Endocrinol (Lausanne); 2023; 14():1102361. PubMed ID: 36755912
[TBL] [Abstract][Full Text] [Related]
24. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
Kitnarong N; Chindasub P; Metheetrairut A
Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
[TBL] [Abstract][Full Text] [Related]
25. Level of vascular endothelial growth factor in aqueous humor and surgical results of ahmed glaucoma valve implantation in patients with neovascular glaucoma.
Kim YG; Hong S; Lee CS; Kang SY; Seong GJ; Ma KT; Kim CY
J Glaucoma; 2009 Aug; 18(6):443-7. PubMed ID: 19680051
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
[TBL] [Abstract][Full Text] [Related]
27. Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.
Li XJ; Yang XP; Li QM; Wang YY; Lyu XB
Chin Med J (Engl); 2015 Aug; 128(15):2078-83. PubMed ID: 26228222
[TBL] [Abstract][Full Text] [Related]
28. Study of clinical applications and safety for Pascal® laser photocoagulation in retinal vascular disorders.
Muqit MM; Sanghvi C; McLauchlan R; Delgado C; Young LB; Charles SJ; Marcellino GR; Stanga PE
Acta Ophthalmol; 2012 Mar; 90(2):155-61. PubMed ID: 20163363
[TBL] [Abstract][Full Text] [Related]
29. Ahmed glaucoma valve implantation for neovascular glaucoma after vitrectomy for proliferative diabetic retinopathy.
Park UC; Park KH; Kim DM; Yu HG
J Glaucoma; 2011 Sep; 20(7):433-8. PubMed ID: 20852440
[TBL] [Abstract][Full Text] [Related]
30. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.
Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594
[TBL] [Abstract][Full Text] [Related]
31. [Current approaches in neovascular glaucoma].
Zhang XL
Zhonghua Yan Ke Za Zhi; 2012 Jun; 48(6):488-91. PubMed ID: 22943801
[TBL] [Abstract][Full Text] [Related]
32. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.
Takihara Y; Inatani M; Fukushima M; Iwao K; Iwao M; Tanihara H
Am J Ophthalmol; 2009 May; 147(5):912-8, 918.e1. PubMed ID: 19195639
[TBL] [Abstract][Full Text] [Related]
33. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
[TBL] [Abstract][Full Text] [Related]
34. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
35. Levels of angiogenesis-related vascular endothelial growth factor family in neovascular glaucoma eyes.
Chen S; Zhou M; Wang W; Wu H; Yu X; Huang W; Gao X; Wang J; Li X; Du S; Ding X; Zhang X
Acta Ophthalmol; 2015 Nov; 93(7):e556-60. PubMed ID: 25783445
[TBL] [Abstract][Full Text] [Related]
36. Long-term results of carbon ion radiation therapy for locally advanced or unfavorably located choroidal melanoma: usefulness of CT-based 2-port orthogonal therapy for reducing the incidence of neovascular glaucoma.
Toyama S; Tsuji H; Mizoguchi N; Nomiya T; Kamada T; Tokumaru S; Mizota A; Ohnishi Y; Tsujii H;
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):270-6. PubMed ID: 23414768
[TBL] [Abstract][Full Text] [Related]
37. Alteration of UCP2 and ZO-1 expression in trabecular meshwork of neovascular glaucoma patients.
Yang JG; Zhou CJ; Li XY; Sun PR; Li SP; Ren BC
J Glaucoma; 2015; 24(4):291-6. PubMed ID: 23835672
[TBL] [Abstract][Full Text] [Related]
38. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
[TBL] [Abstract][Full Text] [Related]
39. Vitrectomy and panretinal photocoagulation reduces the occurrence of neovascular glaucoma in central retinal vein occlusion with vitreous hemorrhage.
Chuang LH; Wang NK; Chen YP; Yeung L; Hwang YS; Chen KJ; Wu WC; Chen TL; Lai CC
Retina; 2013 Apr; 33(4):798-802. PubMed ID: 23114407
[TBL] [Abstract][Full Text] [Related]
40. Clinical Features of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma.
Kim YH; Sung MS; Park SW
Korean J Ophthalmol; 2017 Aug; 31(4):343-350. PubMed ID: 28682017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
